ICU Medical, Inc. $ICUI Shares Acquired by Martingale Asset Management L P

Key Points

• Martingale Asset Management L P has increased its stake in ICU Medical by 28.3%, acquiring an additional 4,761 shares, bringing its total holdings to 21,561 shares worth approximately $2.99 million.
• ICU Medical reported a quarterly earnings per share of $2.10, surpassing analyst expectations, and projected a full-year earnings guidance of 6.850-7.15 EPS for FY 2025.
• Institutional investors own approximately 96.10% of ICU Medical shares, reflecting strong institutional interest in the company.

Martingale Asset Management L P increased its stake in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 28.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 21,561 shares of the medical instruments supplier's stock after purchasing an additional 4,761 shares during the quarter. Martingale Asset Management L P owned 0.09% of ICU Medical worth $2,994,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Wells Fargo & Company MN boosted its stake in ICU Medical by 25.9% in the 4th quarter. Wells Fargo & Company MN now owns 13,543 shares of the medical instruments supplier's stock worth $2,101,000 after buying an additional 2,784 shares during the last quarter. Russell Investments Group Ltd. lifted its holdings in shares of ICU Medical by 88.8% in the fourth quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock valued at $99,000 after buying an additional 300 shares during the period. Mariner LLC lifted its holdings in shares of ICU Medical by 24.4% during the fourth quarter. Mariner LLC now owns 5,009 shares of the medical instruments supplier's stock valued at $777,000 after purchasing an additional 984 shares during the last quarter. CANADA LIFE ASSURANCE Co raised its position in ICU Medical by 0.7% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 28,476 shares of the medical instruments supplier's stock valued at $4,412,000 after buying an additional 188 shares during the period. Finally, Dimensional Fund Advisors LP increased its position in ICU Medical by 18.2% in the 4th quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier's stock worth $83,788,000 after purchasing an additional 82,982 shares during the last quarter. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insider Buying and Selling at ICU Medical

In other news, CEO Vivek Jain acquired 21,929 shares of ICU Medical stock in a transaction that occurred on Thursday, August 14th. The stock was purchased at an average price of $112.84 per share, for a total transaction of $2,474,468.36. Following the purchase, the chief executive officer directly owned 130,149 shares in the company, valued at $14,686,013.16. The trade was a 20.26% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

ICUI has been the topic of several research reports. Raymond James Financial dropped their target price on ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating on the stock in a research report on Friday, August 8th. Piper Sandler started coverage on ICU Medical in a report on Friday, August 15th. They issued an "overweight" rating and a $145.00 target price for the company. Finally, Wall Street Zen cut ICU Medical from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of $179.00.

ICU Medical Trading Up 0.8%

NASDAQ:ICUI traded up $1.04 during trading hours on Wednesday, hitting $126.98. 61,323 shares of the company were exchanged, compared to its average volume of 267,043. The company has a fifty day simple moving average of $126.94 and a 200 day simple moving average of $136.44. ICU Medical, Inc. has a one year low of $107.00 and a one year high of $196.26. The company has a current ratio of 2.44, a quick ratio of 1.17 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $3.13 billion, a price-to-earnings ratio of -83.54 and a beta of 0.88.

ICU Medical (NASDAQ:ICUI - Get Free Report) last issued its earnings results on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.44 by $0.66. The company had revenue of $543.57 million for the quarter, compared to analysts' expectations of $543.33 million. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The firm's quarterly revenue was down 8.0% on a year-over-year basis. During the same quarter last year, the company posted $1.56 earnings per share. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. Sell-side analysts expect that ICU Medical, Inc. will post 4.11 EPS for the current fiscal year.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.